Orforglipron food interaction profile — no fasting requirement

sarah_TO said:

The manufacturing argument is the underrated one.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Printing the relevant bit and taking it with me.

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

KevinCompounds said:

Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Moderator note: the sourcing question belongs in the vendor section and has been split out. Report rather than reply if it drifts again.